ProPhase Labs to Present at The ThinkEquity Conference
October 12 2023 - 8:00AM
ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech,
genomics, therapeutics and diagnostics company, today announced it
will be participating in The ThinkEquity Conference, which will
take place on October 19, 2023 at The Mandarin Oriental Hotel in
New York.
ProPhase Labs’ CEO and Chairman of the Board of
Directors, Ted Karkus will be presenting at 11:30 AM ET on October
19th. Interested parties can register to attend here:
https://www.meetmax.com/sched/event_95483/conference_register.html
One-on-one investor meetings will be held
throughout the day.
The presentation will also be live-streamed at
the following link:
https://wsw.com/webcast/tep24/prph/1691270
About ProPhase Labs
ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase”)
is a next-generation biotech, genomics, therapeutics and
diagnostics company. Our goal is to create a healthier world with
bold action and the power of insight. We’re revolutionizing
healthcare with industry-leading Whole Genome Sequencing solutions,
while developing potential game changer diagnostics and
therapeutics in the fight against cancer. This includes a
potentially life-saving cancer test focused on early detection of
esophageal cancer and potential breakthrough cancer therapeutics
with novel mechanisms of action. Our world-class CLIA labs and
cutting-edge diagnostic technology provide wellness solutions for
healthcare providers and consumers. We develop, manufacture, and
commercialize health and wellness solutions to enable people to
live their best lives. We are committed to executional excellence,
smart diversification, and a synergistic, omni-channel approach.
ProPhase Labs’ valuable subsidiaries, their synergies and
significant growth underscore our multi-billion-dollar
potential.
For more information, visit www.ProPhaseLabs.com.
Media Relations and Institutional Investor
Contact:ProPhase Labs,
Inc.267-880-1111investorrelations@prophaselabs.com
Retail Investor Relations Contact:Renmark
Financial CommunicationsJohn
Boidman514-939-3989Jboidman@renmarkfinancial.com
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Sep 2024 to Oct 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Oct 2023 to Oct 2024